(odds ratio [OR], 0.26; 95% CI, 0.09-0.73; P = .01), the presence of hypotension on admission to the emergency department (OR, 3.35; 95% CI,; P = .01), and higher Injury Severity Score (OR, 1.07; 95% CI, 1.03-1.11; P < .001) (Table) . Only 9 deaths (17.0%) were adjudicated as being preventable, whereas 14 (26.4%) were potentially preventable and 30 (56.6%) were deemed not preventable. After adjustment for preventability, the FTR rate decreased significantly to 13.4% (23 of the 172 patients who experienced a complication after emergency surgery) (Figure) .
The current definition of FTR may be inadequate and overemphasizes variables beyond a trauma system's control. This definition also classifies most nonpreventable deaths as FTR. This classification system leads to an inflated FTR rate that includes many cases in which no "failure" occurred. Incorporation of preventability into definitions of FTR may allow for more precise assessments of surgical performance.
Identifying the characteristics and risk factors in this more specific group may aid in the development of strategies to improve surgical care. In our cohort of all patients who developed a complication after emergency surgery (both preventable and not preventable), we found that 78 patients (45.4%) had a medical complication and 94 (54.6%) had a surgical complication. We have confirmed what others have reported in that lack of insurance is associated with higher rates of FTR.
3 In addition, in our cohort, hypotension on admission to the emergency department and a higher Injury Severity Score were also associated with FTR. Limitations of the study include the retrospective design, a patient cohort from a single institution, and the subjective nature of the determinations of preventability. In addition, some patients who died may have opted to forgo further treatment. Exclusion of those deaths from the preventable group would affect our results.
Future efforts to improve patient care should focus on preventable FTRs. This approach is now part of a national movement embraced by the American College of Surgeons, which has set a goal of zero preventable deaths from trauma.
Beyond the Margins-Economic Costs and Complications Associated With Repeated Breast-Conserving Surgeries
For early stage breast cancer, breast-conserving surgery (BCS) is a compelling alternative to mastectomy, resulting in lower complication rates, 1 equivalent patient-reported quality of life and cosmesis, 2 and equivalent or better survival rates.
3 Unfortunately, these benefits may not be fully realized in women who undergo repeated surgery, usually to increase the resection margin. 4 Although considerable attention has been drawn to this problem, the costs and complications resulting from additional operations are not well-characterized. Herein we present a retrospective review of insurance claims data for BCS patients performed to assess clinical complications and economic outcomes. test with a 2-tailed P value and for costs via 95% CIs. The study was exempt from institutional review board approval and patient informed consent because all data used were deidentified.
Results | Among 9837 women, mean age 53 years, 2282 women (23.2%; 95% CI, 22.4%-24.0%) underwent at least 1 additional breast operation ( Table 2) . Women who underwent an additional operation waited an average of 24 days for the second procedure. The mean cost for a patient undergoing any repeated surgery was $16 072 higher, and 56.4% of those added costs were incurred within 6 months after the initial BCS. The mean 2-year total health care costs increased by $11 621 for patients undergoing a repeated BCS and $26 276 for patients undergoing a subsequent mastectomy. Increased costs owing to a repeated surgery were statistically significant (mean, $89 016; 95% CI, $87 132-$90 899 without an additional surgery vs mean, $105 088; 95% CI, $101 408-$108 768 with a repeated surgery; P <.001).
For women undergoing a repeated surgery, the likelihood of experiencing at least 1 complication was 47.6% higher (relative, 11.2%; absolute, 34.8%; 95% CI, 32.9%-36.7% vs 23.6%; 95% CI, 22.6%-24.6%) and the likelihood of experiencing multiple complications was 89.1% higher (relative, 4.9%; absolute, 5.5%; 95% CI, 5.0%-6.0% vs 10.4%; 95% CI, 9.1%-11.7%) than for patients undergoing a single BCS. For patients undergoing a repeated surgery, infection, hematoma and/or seroma, and fat necrosis were the most common complications. In the 3 months following the initial BCS, complica- tions were twice as likely in patients undergoing a repeated breast surgery (16.2%; 95% CI, 14.7%-17.7% vs 7.9%; 95% CI, 7.3%-8.5%; P < .001). Increased complications owing to a repeated surgery were statistically significant.
Discussion | These data demonstrate that in 23.2% of BCS patients, the full benefits of BCS are not realized owing to the added costs and complications of subsequent surgery. For example, mastectomy is associated with a 15.7% 2-year infection rate,
